Navigating Psoriatic Arthritis and Weight Together in One Care Plan

A veteran's decade-long path through psoriatic arthritis and obesity opens the program, setting up a wide-ranging look at diagnosis, treatment, and the disease's true prevalence.

Kameillia Welch gives a deeply personal account of how one patient finally reached a diagnosis after years of unexplained pain.

Eight medications, one persistent rash, and a run of trial and error trace the real-world difficulty of matching a psoriatic arthritis patient to the drug that finally works.

Obesity affects the majority of patients with psoriatic arthritis and can blunt even the best available biologics, raising the question of weight-based dosing and new treatment tools.

Casual observations about benefits of incretin therapy in patients with psoriatic diseases lead to combination therapy approach and TOGETHER-PsA trial.

Beyond joint counts and skin scores, the panel examines how combination therapy touched a veteran's mental health, and where cardiac, cognitive, and other comorbidity research is heading next.